Upregulation of FOSL2 at 2p22 is associated with colon cancer (Wang et al., 2014), and increased levels of FNDC4 transcripts are associated with increased inflammation in mouse models and in IBD patients (Bosma et al., 2016). The gene discussed is FOSL2; the disease is malignant colon neoplasm.